Bacteriophages and Lysins in Biofilm Control

To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virologica Sinica 2020-04, Vol.35 (2), p.125-133
Hauptverfasser: Łusiak-Szelachowska, Marzanna, Weber-Dąbrowska, Beata, Górski, Andrzej
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133
container_issue 2
container_start_page 125
container_title Virologica Sinica
container_volume 35
creator Łusiak-Szelachowska, Marzanna
Weber-Dąbrowska, Beata
Górski, Andrzej
description To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro , ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.
doi_str_mv 10.1007/s12250-019-00192-3
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7198674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2370505523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</originalsourceid><addsrcrecordid>eNp9kUFPGzEQha0KRCDlD_SAVuLSA0vHY3u9vlSCiLZIkXoBqTfLcezE0Wad2kkl_j0OSdPCgYttaT6_eTOPkE8UrimA_JIpooAaqKqhHFizD-SUKiXqFuHXUXk3ktcgGzUgZzkvABpsGTshA4YURcPZKbm6NXbtUoiruZm5XJl-Wo2fcuhzFfrqNkQfumU1iv06xe4jOfamy-58fw_J47e7h9GPevzz-_3oZlxbLvm6thOjuPMwocwwMIBgrUfhhaOtorb48Y1nQqKlU8spMq4kB0TvQVJnJRuSrzvd1WaydFPrSnfT6VUKS5OedDRBv670Ya5n8Y-WVLVl5iLweS-Q4u-Ny2u9DNm6rjO9i5uskUkQIASygl6-QRdxk_oyXqFUi8gbtXWEO8qmmHNy_mCGgt6GoXdh6JKDfglDb6Uv_h_j8OXv9gvAdkAupX7m0r_e78g-AzRQk50</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398224697</pqid></control><display><type>article</type><title>Bacteriophages and Lysins in Biofilm Control</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</creator><creatorcontrib>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</creatorcontrib><description>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro , ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</description><identifier>ISSN: 1674-0769</identifier><identifier>EISSN: 1995-820X</identifier><identifier>DOI: 10.1007/s12250-019-00192-3</identifier><identifier>PMID: 32125643</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacterial infections ; Bacteriophages - chemistry ; Biochemistry ; Biofilms ; Biofilms - drug effects ; Biomedical and Life Sciences ; Biomedicine ; Communicable Diseases - therapy ; Drug Therapy, Combination ; Humans ; Infections ; Lysins ; Medical Microbiology ; Microbial Genetics and Genomics ; Microbiology ; Oncology ; Phage Therapy ; Phages ; Review ; Urinary tract ; Viral Proteins - therapeutic use ; Virology</subject><ispartof>Virologica Sinica, 2020-04, Vol.35 (2), p.125-133</ispartof><rights>Wuhan Institute of Virology, CAS 2020</rights><rights>Wuhan Institute of Virology, CAS 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</citedby><cites>FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</cites><orcidid>0000-0001-5349-8349 ; 0000-0001-8535-258X ; 0000-0002-0863-6041</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198674/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198674/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,41490,42559,51321,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32125643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Łusiak-Szelachowska, Marzanna</creatorcontrib><creatorcontrib>Weber-Dąbrowska, Beata</creatorcontrib><creatorcontrib>Górski, Andrzej</creatorcontrib><title>Bacteriophages and Lysins in Biofilm Control</title><title>Virologica Sinica</title><addtitle>Virol. Sin</addtitle><addtitle>Virol Sin</addtitle><description>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro , ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacterial infections</subject><subject>Bacteriophages - chemistry</subject><subject>Biochemistry</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Communicable Diseases - therapy</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Infections</subject><subject>Lysins</subject><subject>Medical Microbiology</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Oncology</subject><subject>Phage Therapy</subject><subject>Phages</subject><subject>Review</subject><subject>Urinary tract</subject><subject>Viral Proteins - therapeutic use</subject><subject>Virology</subject><issn>1674-0769</issn><issn>1995-820X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFPGzEQha0KRCDlD_SAVuLSA0vHY3u9vlSCiLZIkXoBqTfLcezE0Wad2kkl_j0OSdPCgYttaT6_eTOPkE8UrimA_JIpooAaqKqhHFizD-SUKiXqFuHXUXk3ktcgGzUgZzkvABpsGTshA4YURcPZKbm6NXbtUoiruZm5XJl-Wo2fcuhzFfrqNkQfumU1iv06xe4jOfamy-58fw_J47e7h9GPevzz-_3oZlxbLvm6thOjuPMwocwwMIBgrUfhhaOtorb48Y1nQqKlU8spMq4kB0TvQVJnJRuSrzvd1WaydFPrSnfT6VUKS5OedDRBv670Ya5n8Y-WVLVl5iLweS-Q4u-Ny2u9DNm6rjO9i5uskUkQIASygl6-QRdxk_oyXqFUi8gbtXWEO8qmmHNy_mCGgt6GoXdh6JKDfglDb6Uv_h_j8OXv9gvAdkAupX7m0r_e78g-AzRQk50</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Łusiak-Szelachowska, Marzanna</creator><creator>Weber-Dąbrowska, Beata</creator><creator>Górski, Andrzej</creator><general>Springer Singapore</general><general>KeAi Publishing Communications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5349-8349</orcidid><orcidid>https://orcid.org/0000-0001-8535-258X</orcidid><orcidid>https://orcid.org/0000-0002-0863-6041</orcidid></search><sort><creationdate>20200401</creationdate><title>Bacteriophages and Lysins in Biofilm Control</title><author>Łusiak-Szelachowska, Marzanna ; Weber-Dąbrowska, Beata ; Górski, Andrzej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-cba94ef0b13a30a020ccf25f5e1891c769f6f3572c1dc41234974022ff071ec73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacterial infections</topic><topic>Bacteriophages - chemistry</topic><topic>Biochemistry</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Communicable Diseases - therapy</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Infections</topic><topic>Lysins</topic><topic>Medical Microbiology</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Oncology</topic><topic>Phage Therapy</topic><topic>Phages</topic><topic>Review</topic><topic>Urinary tract</topic><topic>Viral Proteins - therapeutic use</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Łusiak-Szelachowska, Marzanna</creatorcontrib><creatorcontrib>Weber-Dąbrowska, Beata</creatorcontrib><creatorcontrib>Górski, Andrzej</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Łusiak-Szelachowska, Marzanna</au><au>Weber-Dąbrowska, Beata</au><au>Górski, Andrzej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacteriophages and Lysins in Biofilm Control</atitle><jtitle>Virologica Sinica</jtitle><stitle>Virol. Sin</stitle><addtitle>Virol Sin</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>35</volume><issue>2</issue><spage>125</spage><epage>133</epage><pages>125-133</pages><issn>1674-0769</issn><eissn>1995-820X</eissn><abstract>To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro , ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>32125643</pmid><doi>10.1007/s12250-019-00192-3</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-5349-8349</orcidid><orcidid>https://orcid.org/0000-0001-8535-258X</orcidid><orcidid>https://orcid.org/0000-0002-0863-6041</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1674-0769
ispartof Virologica Sinica, 2020-04, Vol.35 (2), p.125-133
issn 1674-0769
1995-820X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7198674
source MEDLINE; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Anti-Bacterial Agents - therapeutic use
Antibiotics
Bacterial infections
Bacteriophages - chemistry
Biochemistry
Biofilms
Biofilms - drug effects
Biomedical and Life Sciences
Biomedicine
Communicable Diseases - therapy
Drug Therapy, Combination
Humans
Infections
Lysins
Medical Microbiology
Microbial Genetics and Genomics
Microbiology
Oncology
Phage Therapy
Phages
Review
Urinary tract
Viral Proteins - therapeutic use
Virology
title Bacteriophages and Lysins in Biofilm Control
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A38%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacteriophages%20and%20Lysins%20in%20Biofilm%20Control&rft.jtitle=Virologica%20Sinica&rft.au=%C5%81usiak-Szelachowska,%20Marzanna&rft.date=2020-04-01&rft.volume=35&rft.issue=2&rft.spage=125&rft.epage=133&rft.pages=125-133&rft.issn=1674-0769&rft.eissn=1995-820X&rft_id=info:doi/10.1007/s12250-019-00192-3&rft_dat=%3Cproquest_pubme%3E2370505523%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2398224697&rft_id=info:pmid/32125643&rfr_iscdi=true